Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05135650 |
|
Recruitment Status :
Suspended
(Enrollment temporarily on hold for amendment submission)
First Posted : November 26, 2021
Last Update Posted : January 26, 2023
|
Sponsor:
Fred Hutchinson Cancer Center
Collaborators:
National Marrow Donor Program
Vir Biotechnology, Inc.
Information provided by (Responsible Party):
Fred Hutchinson Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Suspended |
|---|---|
| Estimated Primary Completion Date : | January 15, 2024 |
| Estimated Study Completion Date : | January 15, 2024 |